ResMed Inc (RMD)
244.28
+1.81
(+0.75%)
USD |
NYSE |
Nov 01, 16:00
244.26
-0.02
(-0.01%)
After-Hours: 20:00
ResMed Enterprise Value: 36.11B for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 36.11B |
| October 31, 2024 | 35.84B |
| October 30, 2024 | 35.93B |
| October 29, 2024 | 36.13B |
| October 28, 2024 | 36.48B |
| October 25, 2024 | 37.84B |
| October 24, 2024 | 35.34B |
| October 23, 2024 | 35.10B |
| October 22, 2024 | 35.48B |
| October 21, 2024 | 35.49B |
| October 18, 2024 | 35.48B |
| October 17, 2024 | 35.42B |
| October 16, 2024 | 35.23B |
| October 15, 2024 | 35.36B |
| October 14, 2024 | 35.58B |
| October 11, 2024 | 35.55B |
| October 10, 2024 | 35.17B |
| October 09, 2024 | 35.04B |
| October 08, 2024 | 34.90B |
| October 07, 2024 | 34.35B |
| October 04, 2024 | 34.59B |
| October 03, 2024 | 35.25B |
| October 02, 2024 | 35.31B |
| October 01, 2024 | 35.29B |
| September 30, 2024 | 36.08B |
| Date | Value |
|---|---|
| September 27, 2024 | 35.55B |
| September 26, 2024 | 36.07B |
| September 25, 2024 | 35.80B |
| September 24, 2024 | 36.74B |
| September 23, 2024 | 36.64B |
| September 20, 2024 | 36.46B |
| September 19, 2024 | 36.17B |
| September 18, 2024 | 35.44B |
| September 17, 2024 | 37.33B |
| September 16, 2024 | 37.46B |
| September 13, 2024 | 37.04B |
| September 12, 2024 | 37.31B |
| September 11, 2024 | 37.63B |
| September 10, 2024 | 37.62B |
| September 09, 2024 | 37.14B |
| September 06, 2024 | 36.45B |
| September 05, 2024 | 36.43B |
| September 04, 2024 | 36.43B |
| September 03, 2024 | 36.45B |
| August 30, 2024 | 36.47B |
| August 29, 2024 | 36.20B |
| August 28, 2024 | 36.13B |
| August 27, 2024 | 36.06B |
| August 26, 2024 | 33.65B |
| August 23, 2024 | 33.77B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
17.63B
Minimum
Mar 20 2020
43.68B
Maximum
Sep 08 2021
30.88B
Average
31.32B
Median
Dec 09 2020
Enterprise Value Benchmarks
| Boston Scientific Corp | 131.03B |
| Abbott Laboratories | 213.13B |
| Becton Dickinson & Co | 82.01B |
| Insulet Corp | 17.10B |
| Twist Bioscience Corp | 2.146B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 311.36M |
| Revenue (Quarterly) | 1.225B |
| Total Expenses (Quarterly) | 837.20M |
| EPS Diluted (Quarterly) | 2.11 |
| Gross Profit Margin (Quarterly) | 58.57% |
| Profit Margin (Quarterly) | 25.43% |
| Earnings Yield | 3.09% |
| Operating Earnings Yield | 4.11% |
| Normalized Earnings Yield | 3.245 |